Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Ovarian stromal hyperplasia can cause high testosterone in postmenopausal women and is treated by removing the ovaries.

Hormone replacement therapy may improve hair growth in the frontal hairline of postmenopausal women with hair loss.

Finasteride 1mg helps reverse hair miniaturization in men and postmenopausal women.

Oophorectomy lowers testosterone and estrogen levels in both premenopausal and postmenopausal women, with postmenopausal women still producing significant testosterone.

A 5 mg dose of transdermal testosterone cream effectively restores testosterone levels in postmenopausal women.

Soy protein with isoflavones reduces wrinkles and improves skin hydration in postmenopausal women.

GnRH analogue can help diagnose ovarian causes of high testosterone in postmenopausal women when scans don't show the cause.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

High-dose finasteride effectively treats hair loss in postmenopausal women.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Oral and topical finasteride are effective and safe for treating female hair loss.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Testosterone therapy can help postmenopausal women with low sexual desire if monitored carefully.

Snail1 may contribute to fibrosis in frontal fibrosing alopecia in postmenopausal women.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Postmenopausal women can experience hairline recession, affecting their quality of life, and more research is needed for treatments.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

Early postmenopausal women often experience skin issues like vaginal dryness, swallowing difficulties, hair loss, and uncommonly, keratoderma and hirsutism, but many are unaware these are related to menopause.

5% minoxidil foam effectively regrows hair in women, with postmenopausal women seeing the most improvement.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

Removing both ovaries can treat increased testosterone and related symptoms in postmenopausal women with ovarian hyperthecosis.

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

Postmenopausal frontal fibrosing alopecia is a type of hair loss in postmenopausal women that may stop on its own but has no effective treatment.

Hair loss in postmenopausal women due to ovarian hyperthecosis is rare, but removing the ovaries can significantly improve the condition.

The document concludes that doctors should thoroughly check postmenopausal women with sudden increased male traits for rare conditions like androgen-producing endometrial cancer.